A systematic review of 43 studies encompassing 5,217 patients and controls demonstrated aPL involvement in 17.4% of cerebrovascular events, 17.2% of strokes, and 11.7% of transient ischemic attacks, conferring a fivefold increased stroke or transient ischemic attack risk (103). This evidence concerns the gene FASLG and Stroke.